The finding that KEAP1 transcript levels are modulated by methylation only in KRAS wild-type NSCLC might indicate that methylation is a KRAS-independent mechanism to modulate NRF2 levels in tumor cells. The gene discussed is KRAS; the disease is neoplasm.